Dr Zu-Chian Chiang | Biological macromolecules | Best Researcher Award |

Published on by Award and Honors

Dr. Zu-Chian Chiang | Biological macromolecules | Best Researcher Award | 

Postdoctoral Fellow, at Fujian Normal University ,China

Dr. Zu-Chian Chiang (蔣祖搴), Ph.D., is a dedicated postdoctoral researcher currently working at the Biomedical Research Center of Southern China, Fujian Normal University, Qishan Campus, Fuzhou, China. With a strong academic and research foundation rooted in Taiwan, Dr. Chiang has developed expertise in biomedical sciences, materials chemistry, and clinical applications of advanced therapeutic technologies. He has worked with prestigious institutions such as Academia Sinica and National Taiwan University Hospital, contributing significantly to translational medicine, particularly in targeted cancer therapy and regenerative medicine. His collaborative and cross-disciplinary approach reflects a deep commitment to scientific advancement and public health.

Professional Profile

Scopus

Education 🎓

Dr. Chiang earned his Ph.D. in Materials and Chemical Engineering from the College of Engineering and Science at National United University, Taiwan (2008–2014), where he also served as a teaching assistant across various chemistry and engineering courses. He completed his M.S. in Chemistry at Tunghai University, Taiwan (2005–2007), laying the foundation for his specialization in organic chemistry and material science. His academic path has been enriched by mentorship from notable scholars such as Prof. An-Chong Chao and Prof. Feng-Di Lung.

Experience 👩‍

Dr. Chiang has over a decade of research experience across Taiwan and China. His postdoctoral journey began at the Clinical Trial Center of National Taiwan University Hospital, followed by appointments at Academia Sinica’s Institute of Biological Chemistry under the Taiwan Protein Project and Translational Innovation programs. Since 2019, he has been a postdoctoral fellow at Fujian Normal University, collaborating with Prof. Qi Chen. He also brings a strong teaching background, having served as a teaching and lab assistant in various chemistry and engineering courses during his graduate studies.

Research Interests 🔬

Dr. Chiang’s research centers on the development of functional peptides and biopolymeric complexes for cancer research and bone tissue engineering. He specializes in cutting-edge areas such as Antibody-Drug Conjugates (ADCs) for targeted cancer therapy, specific aptamers used as molecular agonists or antagonists, and the synthesis of multifunctional biomaterials for regenerative medicine. His interdisciplinary work bridges the gap between chemical engineering and biomedical applications, aiming to design smarter and more effective therapeutic strategies.

Awards 🏆

Dr. Chiang has been recognized for his excellence with several prestigious awards, including the 2020 Science and Technology Commissioner of Quanzhou (Fujian Province) and the 3rd Biotech Elite Training Reserve Program Award by the Executive Yuan, Taiwan. Other accolades include the Chung Hwa Rotary Doctoral Program Award (2012), the Outstanding Doctoral Scholarship at National United University (2010), and the Master’s Program Scholarship from the Hunan Fellow Association (2007). His leadership is also recognized by Rotary International through various honors and leadership roles.

Top Noted Publications 📚

Dr. Chiang has authored and co-authored several impactful publications in international journals. His recent works include:

Development of 7DC-DM1, a CD47-targeting ADC with anti-tumor effects (IJ Biological Macromolecules, 2025).

Immuno-enhancement in lung cancer therapy via thalidomide and anti-PD-1 antibodies (Current Pharmaceutical Biotechnology, 2024).

CD47-specific ADCs for NSCLC treatment, demonstrating strong preclinical efficacy (Frontiers in Oncology, 2022).

Conclusion

Dr. Zu-Chian Chiang is a highly accomplished and promising researcher in the biomedical sciences, with a proven track record of impactful research, academic excellence, and leadership. His interdisciplinary expertise, from molecular synthesis to clinical trial collaboration, positions him as an outstanding candidate for any Best Researcher Award. With his continued contributions to science and society, Dr. Chiang exemplifies the qualities of innovation, dedication, and global impact.

Dr KEVIN IGOR AZEUDA NDONFACK | Economic Geology | Best Researcher Award |

Published on by Award and Honors

Dr. KEVIN IGOR AZEUDA NDONFACK | Economic Geology | Best Researcher Award| 

Geologist , at JCHX Mining Management company, LTD, China.

Dr. Kevin Igor Azeuda Ndonfack is an accomplished early-career geologist with a deep passion for economic geology and mineral exploration. He has a dynamic professional background that bridges academia and industry, currently serving as a Postdoctoral Geologist Engineer at JCHX Mining Management Co., Ltd. and as a Researcher at the Chinese Academy of Geological Sciences. Fluent in English, French, and Chinese, Dr. Azeuda is a multilingual scientific communicator who has made significant contributions to the discovery and understanding of copper and gold deposits across the Central African Copperbelt. His strong problem-solving skills, field expertise, and analytical mindset make him a rising star in the global geoscience community.

Professional Profile

Orcid

Education 🎓

Dr. Azeuda earned his Doctorate in Engineering (Mining Engineering – Economic Geology) from the University of Science and Technology Beijing, China (2017–2022), with a thesis focused on primary gold deposits in the Pan-African Orogeny of Eastern Cameroon. Prior to that, he obtained a Master’s degree in Petrology-Tectonics and Natural Resources and a Bachelor’s degree in Earth Sciences from the University of Yaoundé I, Cameroon. He also pursued Chinese language training at USTB to better integrate into his academic and professional environment in China.

Experience 👩‍

Dr. Azeuda is currently leading geological research and field operations at JCHX Mining and the Chinese Academy of Geological Sciences, focusing on mineral exploration in the Central African region. He is actively involved in core sampling, field mapping, data management, and multilingual document translation for cross-border collaboration. He has contributed significantly to the discovery of the Lonshi-East copper deposit (26Mt @ 3.99% Cu) and has established a geotectonic model for sediment-hosted copper deposits that is referenced in ongoing exploration projects.

Research Interests 🔬

Dr. Azeuda’s research is centered around the exploration geology and geochemistry of ore deposits, with a special emphasis on sediment-hosted and orogenic gold and copper deposits. He has investigated key mineralized systems such as the Lonshi and Dikulushi copper deposits, along with others in the Central African Copperbelt including Kamoa, Kipushi, and Chambeshi. His work combines field exploration, drill core logging, mineralogy, geochemical analysis, isotopic dating, and the application of AI in ore deposit modeling, aiming to unravel the geological processes that control mineralization.

Awards 🏆

Dr. Azeuda has received multiple prestigious awards recognizing his academic and research excellence. In 2023, he was awarded 400,000 RMB in postdoctoral research funding by the Beijing Municipal Government. He also received the First Prize for Cameroonian Excellence PhD from the Cameroon Embassy in China (2022), and the Outstanding Graduate Student Award from USTB. His international recognition includes the SEG Grant (Chile), the GeoHost Award at the 36th IGC in India, and awards from JCHX and his host university in Beijing for his research publications and conference achievements.

Top Noted Publications 📚

1. Geology, geochemistry, and exploration of the Central African Copperbelt: a review
Authors: Kevin Igor Azeuda Ndonfack, Zhiming Yang, Jinlin Zhang, Scott A. Whattam, Yuling Xie
Journal: International Geology Review
Year: 2024
DOI: 10.1080/00206814.2024.2426200
Index: SCI (Web of Science)

2. Source of metals related to gold occurrences in Cameroon, Central African Belt
Authors: Kevin Igor Azeuda Ndonfack, Jinlin Zhang, Yuling Xie, N. Samiratou Yaya, Emmanuel Archelaus Afanga Basua
Journal: Acta Geochimica
Year: 2024
DOI: 10.1007/s11631-023-00669-9
Index: SCI (Web of Science)

3. Gold occurrences of the Woumbou–Colomine–Kette district, eastern Cameroon: ore-forming constraints from petrography, SEM–CL imagery, fluid inclusions, and C–O–H–S isotopes
Authors: Kevin Igor Azeuda Ndonfack, Yuling Xie, Richard Goldfarb
Journal: Mineralium Deposita
Year: 2022
DOI: 10.1007/s00126-021-01050-7
Index: SCI (Web of Science)

4. Soil Deformation around a Cylindrical Cavity under Drained Conditions: Theoretical Analysis
Authors: Pieride Mabe Fogang, Yang Liu, Jiale Zhao, Kevin Igor Azeuda Ndonfack, Paolo S. Valvo
Journal: Advances in Civil Engineering
Year: 2022
DOI: 10.1155/2022/4127660
Index: SCI (Web of Science)

5. Tectonic evolution of Neoproterozoic rocks, eastern Cameroon: Implication for gold mineralization in the Bétaré Oya and Woumbou–Colomine–Kette districts
Author: Kevin Igor Azeuda Ndonfack
Journal: Precambrian Research
Year: 2022
DOI: 10.1016/j.precamres.2021.106475
Index: SCI (Web of Science)

Conclusion

Kevin Igor Azeudandonfack’s achievements in high-impact research, international recognition, and real-world mining contributions clearly position him as a top candidate for a Best Researcher Award, especially in the early-career category. His interdisciplinary expertise, publication record, and multilingual fluency further enhance his profile.

To strengthen future nominations, he might:

Lead or co-lead more international research networks

Engage in academic peer reviewing or journal editing

Showcase any innovation or AI-based tools developed

Highlight mentorship, teaching, or outreach work

Dr Rina Kansal | Health Professions | Best Researcher Award |

Published on by Award and Honors

Dr.Rina Kansal | Health Professions | Best Researcher Award| 

Physician , at University at Buffalo, United States.

Dr. Rina Kansal is an accomplished physician-scientist and board-certified pathologist specializing in molecular oncology, hematopathology, and medical genetics. With a dynamic career that spans clinical diagnostics, academic leadership, and translational research, Dr. Kansal has consistently demonstrated excellence across multiple domains of pathology. Her journey reflects a rare blend of deep clinical expertise, rigorous academic training, and an enduring commitment to precision medicine. She has held leadership roles in top institutions and has been recognized nationally for her contributions to medical science and healthcare.

Professional Profile

Scopus

Orcid

Google Scholar

Education 🎓

Dr. Kansal began her medical journey at Maulana Azad Medical College, University of Delhi, graduating with an M.B.B.S. degree in 1986. She later earned multiple prestigious credentials, including Diplomate certifications from the American Board of Pathology in Anatomic & Clinical Pathology (1999), Hematopathology (2000), and Molecular Genetic Pathology (original certification 2014, updated in 2024). She also holds certifications in Medical Education Research (2022) and has passed international licensing exams including the USMLE, PLAB (UK), and MRCP Part 1 (UK). Her postgraduate training includes fellowships in Molecular Genetic Pathology at UCLA, Hematopathology at the University of Michigan, and Oncologic Pathology at Roswell Park Cancer Institute.

Experience 👩‍

Dr. Kansal most recently served as Associate Medical Director in Molecular Oncology and Genetics at the Blood Center of Wisconsin (Versiti), where she led clinical diagnostics and molecular testing strategies. She previously held academic appointments as Associate Professor of Pathology at Penn State University, and served as Staff Hematopathologist and Visiting Scientist at Cedars-Sinai Medical Center in Los Angeles. Earlier in her career, she directed Hematopathology and Flow Cytometry at the Medical College of Wisconsin. Throughout her positions, she has combined patient care, diagnostics, education, and research to deliver impactful medical solutions.

Research Interests 🔬

Dr. Kansal’s research lies at the intersection of molecular diagnostics, hematologic malignancies, and personalized medicine. Her work explores the application of advanced genetic tools for diagnosing blood cancers and solid tumors, bridging clinical practice with molecular innovation. She has pursued scholarly activities in flow cytometry, cytogenetics, and next-generation sequencing, contributing to evolving paradigms in molecular pathology. Through her experience at Cedars-Sinai, UCLA, and Penn State Hershey Medical Center, she has remained deeply engaged in translational research with a strong focus on precision medicine.

Awards 🏆

Dr. Kansal has received numerous accolades throughout her career. In 2024, she was honored as a Top Scholar in Precision Medicine by ScholarGPS and selected for the American Society of Hematology’s Advocacy Leadership Institute in Washington, D.C. She was named Top Doctor by regional magazines for Buffalo, NY (2021) and Hershey, PA (2019). She earned a Leadership Institute Certification from the American Society for Clinical Pathology in 2019, and previously received recognition from Labome for her AAAS membership. Her clinical excellence was also commemorated with a service award from the University of Michigan’s Hematopathology Department in 2001.

Top Noted Publications 📚

Title: Towards a one-time cure for Fabry disease: Lentivirus-mediated haematopoietic stem and progenitor cell gene therapy
Author: Rina R. Kansal
Citations: 0

Title: The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies
Author: Rina R. Kansal
Citations: 3

Conclusion

Dr. Rina Kansal possesses outstanding credentials in molecular pathology and hematology, with leadership roles, prestigious fellowships, and recent recognitions. However, for a Best Researcher Award, especially on a national or international scale, her CV would benefit from:

A clear list of publications

Evidence of ongoing funded research

Demonstrated impact in the academic or research community